APR 14, 2020 8:00 AM PDT

Urchin-shaped DNA Biosensor Detects Disease Earlier

WRITTEN BY: Tara Fernandez

 

For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good things come in small packages. With their novel DNA biosensor technology, they have created an inexpensive, ultrasensitive diagnostic tool that is capable of catching cancer and genetic diseases faster and more accurately.

Professor of chemistry, Risheng Wang led a team that published a study featured in the journal Analytical Chemistry, demonstrating the precision and time-saving potential of this discovery.

“Biosensing with nanomaterials has the advantages of greater sensitivity and faster response than traditional analytical methods that require today's medical devices and time-consuming molecular amplification techniques,” said Wang.

What are DNA biosensors? In general, they consist of three major elements: a recognition element that binds specifically to a biological target, a signal converter that transmits information and a processor. The sensor can pick up characteristic patterns on the levels of various biological molecules in a patient’s sample: from nucleic acids to protein antibodies.

 

 

The biosensor designed by Wang and team had a distinctive spheroidal molecular structure that resembled the shape of a sea urchin, consisting of carbon nanotubes and gold nanoparticles. The specific structural conformation and the chosen materials resulted in the biosensor’s robust electrochemical output.

Wenyan Liu, co-author on the research article provided insights on why this innovative platform outperforms currently-available diagnostic systems, saying, “Because the combination of carbon nanotubes and gold nanoparticles produced a larger-than-normal, super-conductive contact area, we found this biosensor could detect the ultralow-abundance nucleic acids in complex biological media.”

This fusion of biomedical engineering, nanotechnology, point-of-care diagnostics and biology could be a critical inflection point for how we diagnose and treat chronic diseases in future.



Sources: Analytical Chemistry, Phys Org.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 20, 2019
Clinical & Molecular DX
NOV 20, 2019
New diagnostic technology seeks out cancer DNA in blood
For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malig ...
DEC 11, 2019
Health & Medicine
DEC 11, 2019
Can optical illusions help diagnose autism?
At first glance what do you see -- a young woman? Or perhaps a smooth jazz artist? This classic optical illusion occurs ...
DEC 11, 2019
Clinical & Molecular DX
DEC 11, 2019
New 3-in-1 organ in a dish set to elevate research and diagnostics
In trying to understand complex phenomena in the human body, researchers usually have to turn to oversimplified biologic ...
FEB 26, 2020
Clinical & Molecular DX
FEB 26, 2020
Is your kid's stomach ache from appendicitis? Probably not.
Complaints about a painful belly are a common childhood lament. In such situations, the first thing that often comes to ...
FEB 21, 2020
Clinical & Molecular DX
FEB 21, 2020
Diagnosing COVID-19
Diagnosing coronavirus is done through next-generation sequencing, real-time RT-PCR tests, cell culture, and electron mi ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
Loading Comments...